Roche FY08 FY Revenues: $43.3 billion (-1%) FY Earnings: $10.3 billion (-5%) Comments: Total sales were up 6% in local currencies (-1% in Swiss francs; +10% in U.S. dollars), with the Pharmaceuticals Division representing 79% of group sales and the Diagnostics Division contributing 21%, compensating for the decline in Tamiflu pandemic sales (down $1.5 billion to $577.7 million) due to reduced pandemic stockpiling orders. Pharmaceutical sales were $34.1 billion (-2% CHF, +8% USD). Genent...